breast cancer susceptibility gene-2 [BRCA-2]
Jump to navigation
Jump to search
Introduction
Germline mutations associated with 35% of families with multiple case early onset female breast cancer; also associated with increased risk of male breast cancer, ovarian cancer, prostate cancer & pancreatic cancer.
The likelihood of breast cancer varies substantially among BRCA1 & BRCA2 mutation carriers, most likely due to additional risk factors.[4]
More general terms
Additional terms
References
- ↑ Wooster R, Stratton MR. Breast cancer susceptibility: a complex disease unravels. Trends Genet. 1995 Jan;11(1):3-5. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/7900193
- ↑ Gayther SA, Ponder BA. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing. Mol Med Today. 1997 Apr;3(4):168-74. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/9134530
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- ↑ 4.0 4.1 Begg CB etl al, Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008, 299:194 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18182601